Robert W. Peabody
Geschäftsführer bei ES Cell International Pte Ltd.
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Adi Mohanty | M | 57 |
Cell Cure Neurosciences Ltd.
Cell Cure Neurosciences Ltd. BiotechnologyHealth Technology Cell Cure Neurosciences Ltd. develops cell therapies for neural degenerative diseases. Its therapeutic cells include retinal pigmented epithelial (RPE) cells and neural progenitor cells. The firm's cells are derived from human embryonic stem cells (hESCs), which are considered to be the gold standard source of cells for the development of stem cell therapies. The company was founded in 2005 and is headquartered in Jerusalem, Israel. | 5 Jahre |
Michael West | M | 71 |
OrthoCyte Corp.
OrthoCyte Corp. Pharmaceuticals: MajorHealth Technology Part of Lineage Cell Therapeutics, Inc., OrthoCyte Corp. develops cellular therapeutics for orthopedic repair diseases and injuries. The company is based in Alameda, CA. The CEO of the company is Michael D. West. | - |
David Schlachet | M | 78 |
Cell Cure Neurosciences Ltd.
Cell Cure Neurosciences Ltd. BiotechnologyHealth Technology Cell Cure Neurosciences Ltd. develops cell therapies for neural degenerative diseases. Its therapeutic cells include retinal pigmented epithelial (RPE) cells and neural progenitor cells. The firm's cells are derived from human embryonic stem cells (hESCs), which are considered to be the gold standard source of cells for the development of stem cell therapies. The company was founded in 2005 and is headquartered in Jerusalem, Israel. | 5 Jahre |
Michael Mulroy | M | 58 | 10 Jahre | |
Neal Bradsher | M | 58 | 15 Jahre | |
Deborah Andrews | F | 66 | 10 Jahre | |
Angus Russell | M | 68 | 10 Jahre | |
Rami Skaliter | M | 66 |
Cell Cure Neurosciences Ltd.
Cell Cure Neurosciences Ltd. BiotechnologyHealth Technology Cell Cure Neurosciences Ltd. develops cell therapies for neural degenerative diseases. Its therapeutic cells include retinal pigmented epithelial (RPE) cells and neural progenitor cells. The firm's cells are derived from human embryonic stem cells (hESCs), which are considered to be the gold standard source of cells for the development of stem cell therapies. The company was founded in 2005 and is headquartered in Jerusalem, Israel. | 7 Jahre |
Benjamin Reubinoff | M | - |
Cell Cure Neurosciences Ltd.
Cell Cure Neurosciences Ltd. BiotechnologyHealth Technology Cell Cure Neurosciences Ltd. develops cell therapies for neural degenerative diseases. Its therapeutic cells include retinal pigmented epithelial (RPE) cells and neural progenitor cells. The firm's cells are derived from human embryonic stem cells (hESCs), which are considered to be the gold standard source of cells for the development of stem cell therapies. The company was founded in 2005 and is headquartered in Jerusalem, Israel. | 18 Jahre |
Raf Hofstein | M | 74 |
Cell Cure Neurosciences Ltd.
Cell Cure Neurosciences Ltd. BiotechnologyHealth Technology Cell Cure Neurosciences Ltd. develops cell therapies for neural degenerative diseases. Its therapeutic cells include retinal pigmented epithelial (RPE) cells and neural progenitor cells. The firm's cells are derived from human embryonic stem cells (hESCs), which are considered to be the gold standard source of cells for the development of stem cell therapies. The company was founded in 2005 and is headquartered in Jerusalem, Israel. | - |
Bruce P. Davidson | M | - |
ES Cell International Pte Ltd.
ES Cell International Pte Ltd. BiotechnologyHealth Technology ES Cell International Pte Ltd. develops human embroyonic stem cell technologies for research and commercial applications. It develops an array of intellectual property in the fields of drug discovery, diagnostics, and therapeutics based on stem cell technology. The company was founded by Ariff Bongso, Robert Klupacs, Martin F. Pera, Reubinoff Benjamin and Alan Osborne Trounson in 2000 and is headquartered in Singapore. | - |
Wai-Ming Yap | M | - |
ES Cell International Pte Ltd.
ES Cell International Pte Ltd. BiotechnologyHealth Technology ES Cell International Pte Ltd. develops human embroyonic stem cell technologies for research and commercial applications. It develops an array of intellectual property in the fields of drug discovery, diagnostics, and therapeutics based on stem cell technology. The company was founded by Ariff Bongso, Robert Klupacs, Martin F. Pera, Reubinoff Benjamin and Alan Osborne Trounson in 2000 and is headquartered in Singapore. | - |
Michael D. West | M | - |
Cell Cure Neurosciences Ltd.
Cell Cure Neurosciences Ltd. BiotechnologyHealth Technology Cell Cure Neurosciences Ltd. develops cell therapies for neural degenerative diseases. Its therapeutic cells include retinal pigmented epithelial (RPE) cells and neural progenitor cells. The firm's cells are derived from human embryonic stem cells (hESCs), which are considered to be the gold standard source of cells for the development of stem cell therapies. The company was founded in 2005 and is headquartered in Jerusalem, Israel. | 22 Jahre |
Francine Del Ricci | F | - |
Cell Cure Neurosciences Ltd.
Cell Cure Neurosciences Ltd. BiotechnologyHealth Technology Cell Cure Neurosciences Ltd. develops cell therapies for neural degenerative diseases. Its therapeutic cells include retinal pigmented epithelial (RPE) cells and neural progenitor cells. The firm's cells are derived from human embryonic stem cells (hESCs), which are considered to be the gold standard source of cells for the development of stem cell therapies. The company was founded in 2005 and is headquartered in Jerusalem, Israel. | - |
Jennifer Bahr-Davidson | M | - | 14 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Peter García | M | 62 | 2 Jahre | |
William M. Caldwell | M | 76 | 5 Jahre | |
Franklin Berger | M | 74 | 1 Jahre | |
Russell Skibsted | M | 65 | 4 Jahre | |
Henry Nordhoff | M | 82 | 1 Jahre | |
Arnold I. Burns | M | 94 | 4 Jahre | |
Stephen Farrell | M | 59 | 7 Jahre | |
Alan C. Shapiro | M | 78 | 11 Jahre | |
Ivan Wolkind | M | 56 | 3 Jahre | |
Abraham E. Cohen | M | 87 | - | |
Erkki Ruoslahti | M | 84 | 6 Jahre | |
Pedro Lichtinger | M | 70 | 5 Jahre | |
Jonathan F. Atzen | M | 59 | 3 Jahre | |
Andrew von Eschenbach | M | 82 | 3 Jahre | |
Lesley A. Stolz | M | 60 | 1 Jahre | |
Rita Parker | F | - | - | |
William P. Tew | M | 77 | 4 Jahre | |
Stephen Price | M | - | - | |
Pedro Huertas | M | 69 | - | |
Jeffrey B. Nickel | M | 80 | - | |
Walter Funk | M | 64 | 3 Jahre | |
Robert N. Butler | M | 97 | 2 Jahre | |
Alan G. Walton | M | 87 | 3 Jahre | |
Alfred Kingsley | M | 81 | 15 Jahre | |
Jeffrey D. Janus | M | 68 | 3 Jahre | |
James Gordon Stewart | M | 71 | 1 Jahre | |
Steve Cartt | M | 61 | 2 Jahre | |
Robert P. Lanza | M | 68 | 17 Jahre | |
David Jin | M | 56 | 8 Jahre |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Vereinigte Staaten | 37 | 84,09% |
Israel | 7 | 15,91% |
Singapur | 2 | 4,55% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Robert W. Peabody
- Persönliches Netzwerk